Overview: Anti-Sperm Antibody TestIntroduction: The Anti-Sperm Antibody Test detects antibodies that may affect fertility by attacking sperm, causing infertility or recurrent miscarriages. Following 2023 ASRM guidelines, it uses an immunoassay for high sensitivity, aiding in fertility screening. This test is critical for guiding fertility treatment, monitoring immune responses, and improving outcomes in immunology for patients with fertility issues.
Other Names: Anti-Sperm Ab Assay, Sperm Antibody Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Anti-sperm antibody testing began in the 1970s with agglutination methods. Immunoassays emerged in the 1990s, and by the 2000s, high-sensitivity assays improved fertility assessment.
Purpose: Diagnoses immune-related infertility, guides fertility treatment, and monitors antibody levels in patients with infertility or recurrent miscarriages.
Test Parameters: 1. Anti Sperm Antibody
Pretest Condition: No fasting required. Collect serum, semen, or saliva at any time. Report infertility history or miscarriages, and list medications like immunosuppressants.
Specimen: 2-5 mL serum (SST), 1-5 mL semen (sterile container), or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document infertility, miscarriages, or history of testicular injury. Include current medications, especially immunosuppressants or fertility drugs.
Consent: Written consent required, detailing the tests purpose, implications for fertility planning, and potential need for treatment or further testing.
Procedural Considerations: Uses an immunoassay to measure anti-sperm antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Recent infections or immunosuppressive drugs may alter antibody levels. Improper storage can degrade samples.
Clinical Significance: Positive results indicate immune-related infertility, prompting immunosuppressive therapy or assisted reproductive techniques. Negative results may require other fertility tests.
Specialist Consultation: Consult a reproductive endocrinologist for result interpretation. A urologist referral is advised for male infertility cases.
Additional Supporting Tests: Semen analysis, post-coital test, or hormone testing to confirm infertility causes or assess treatment options.
Test Limitations: False negatives may occur with low-level antibodies. Results require clinical correlation with fertility history.
References: ASRM Infertility Guidelines, 2023; Fertility and Sterility, Bronson R, 2022.
